Alshalan Afrah, Alzhrani Farid
Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Jouf University, PO Box 72418, 23235, Skaka, Aljouf, Saudi Arabia.
King Abdullah Ear Specialist Center (KAESC), King Saud University, Riyadh, Saudi Arabia.
Eur Arch Otorhinolaryngol. 2024 Jun;281(6):2849-2859. doi: 10.1007/s00405-024-08629-6. Epub 2024 Apr 22.
The indications of Vibrant Soundbridge (VSB) have been expanded to include patients with conductive and mixed hearing loss due to congenital aural atresia (CAA). However, the current evidence supporting the auditory outcomes of VSB is based mainly on case reports and retrospective chart reviews. Therefore, the present systematic review aims to summarize and critically appraise the current evidence regarding the safety and effectiveness of VSB in children and adult patients with CAA.
A systematic literature search retrieved studies that evaluated the outcomes of unilateral or bilateral implantation of VSB in patients with CAA. The bibliographic search was conducted in PubMed, Scopus, EBSCO, and Cochrane Central Register of Controlled Trials (CENTRAL) databases from January 2000 to December 2022.
Twenty-seven studies were included in the present systematic review. Overall, the speech perception after VSB was good, with a mean word recognition score (WRS) score ranging from 60 to 96.7%. The mean postoperative speech recognition threshold (SRT) after implantation ranged from 20.8 to 50 dB. The effective gain was reported in 15 studies, ranging from 31.3 to 45.5 dB. In terms of user satisfaction with VSB, the included studies showed significant improvements in the patient-reported outcomes, such as the Speech Spatial and Qualities of Hearing scale and Glasgow Hearing Aid Benefit Profile. The VSB implantation was generally safe with low incidence of postoperative complications.
VSB provides significant benefits to individuals with hearing loss owing to CAA, with very good subjective outcomes and a low risk of complications.
振动声桥（VSB）的适应证已扩大到包括先天性耳道闭锁（CAA）导致的传导性和混合性听力损失患者。然而，目前支持VSB听觉效果的证据主要基于病例报告和回顾性病历审查。因此，本系统评价旨在总结并批判性评价目前关于VSB在儿童和成人CAA患者中的安全性和有效性的证据。
通过系统的文献检索，获取评估VSB在CAA患者中单侧或双侧植入效果的研究。于2000年1月至2022年12月在PubMed、Scopus、EBSCO和Cochrane对照试验中央注册库（CENTRAL）数据库中进行文献检索。
本系统评价纳入了27项研究。总体而言，VSB植入后的言语感知良好，平均单词识别得分（WRS）在60%至96.7%之间。植入后的平均术后言语识别阈值（SRT）在20.8至50 dB之间。15项研究报告了有效增益，范围在31.3至45.5 dB之间。在用户对VSB的满意度方面，纳入的研究显示患者报告的结局有显著改善，如言语空间和听力质量量表以及格拉斯哥助听器效益概况。VSB植入总体安全，术后并发症发生率低。
VSB为因CAA导致听力损失的个体带来显著益处，主观效果非常好，并发症风险低。
